PI
BIIB icon

Placemark Investments’s Biogen BIIB Stock Holding History

Placemark Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$17.3M Sell
51,030
-5,857
-10% -$1.89M 0.31% 66
2014
Q3 		$18.8M Buy
56,887
+7,196
+14% +$2.37M 0.35% 54
2014
Q2 		$15.7M Buy
49,691
+6,079
+14% +$1.83M 0.28% 71
2014
Q1 		$13.3M Sell
43,612
-2,341
-5% -$743K 0.26% 77
2013
Q4 		$12.8M Buy
45,953
+455
+1% +$118K 0.21% 110
2013
Q3 		$11M Sell
45,498
-673
-1% -$151K 0.21% 114
2013
Q2 		$9.94M Buy
+46,171
New +$9.87M 0.21% 113

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Placemark Investments's BIIB Position: Q4 2014 in Review

Placemark Investments reduced its Biogen (BIIB) stake by 10% in Q4 2014, selling an estimated $1.89M and leaving 51,030 shares worth $17.3M. The position accounts for 0.31% of the portfolio, ranked #66.

Placemark Investments first reported a position in BIIB in Q2 2013 and has held it in 7 quarters since. The position peaked at $18.8M in Q3 2014. 884 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

  • Placemark Investments held 51,030 shares of Biogen worth $17.3M as of Q4 2014.
  • Placemark Investments sold 5,857 Biogen shares in Q4 2014, an estimated $1.89M.
  • Biogen made up 0.31% of Placemark Investments's portfolio in Q4 2014, its #66 holding.
  • Placemark Investments first reported a position in Biogen in Q2 2013 and has held it in 7 quarters since.
  • Placemark Investments's Biogen position peaked at $18.8M in Q3 2014.
  • 884 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.